Why is cardiovascular risk stratification important in hypertensive patients?

Coll-de-Tuero G, Saez M, Rodríguez-Poncelas A, Barceló MA, Vargas-Vila S, Garré-Olmo J, Sala V, Sieira A, Gelada E, Gelado-Ferrero J. Blood Pressure 2012; 21(3):182-190. doi: 10.3109/08037051.2012.681109 (Impact Factor: 2.292, PERIPHERAL VASCULAR DISEASE 38/65 Q3)

Clinical epidemiology FRCV GLM model Method:Generalized models Q3 Selection on observables:Regression models White coat
See article: https://pubmed.ncbi.nlm.nih.gov/22486493/
See article: https://pubmed.ncbi.nlm.nih.gov/22486493/
Research